Inhibition of cyclin-dependent kinases improves CA1 neuronal survival and behavioral performance after global ischemia in the rat - PubMed (original) (raw)

Inhibition of cyclin-dependent kinases improves CA1 neuronal survival and behavioral performance after global ischemia in the rat

Fuhu Wang et al. J Cereb Blood Flow Metab. 2002 Feb.

Abstract

Increasing evidence suggests that cyclin-dependent kinases participate in neuronal death induced by multiple stresses in vitro. However, their role in cell death paradigms in vivo is not well characterized. Accordingly, the authors examined whether cyclin-dependent kinase inhibition resulted in functionally relevant and sustained neuroprotection in a model of global ischemia. Intracerebroventricular administration of the cyclin-dependent kinase inhibitor flavopiridol, immediately or at 4 hours postreperfusion after a global insult, reduced injury in the CA1 of the hippocampus when examined 7 days after reperfusion. No significant protection was observed when flavopiridol was administered 8 hours after reperfusion. The tumor-suppressor retinoblastoma protein, a substrate of cyclin-dependent kinase, was phosphorylated on a cyclin-dependent kinase consensus site after the global insult; this phosphorylation was inhibited by flavopiridol administration. Importantly, flavopiridol had no effect on core body temperature, suggesting that the mechanism of neuroprotection was through cyclin-dependent kinase inhibition but not through hypothermia. Furthermore, inhibition of cyclin-dependent kinases improved spatial learning behavior as assessed by the Morris water maze 7 to 9 days after reperfusion. However, the histologic protection observed at day 7 was absent 28 days after reperfusion. These results indicate that cyclin-dependent kinase inhibition provides an extended period of morphologic and functional neuroprotection that may allow time for other neuroprotective modalities to be introduced.

PubMed Disclaimer

Cited by

Multiple cyclin-dependent kinases signals are critical mediators of ischemia/hypoxic neuronal death in vitro and in vivo.
Rashidian J, Iyirhiaro G, Aleyasin H, Rios M, Vincent I, Callaghan S, Bland RJ, Slack RS, During MJ, Park DS. Rashidian J, et al. Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):14080-5. doi: 10.1073/pnas.0500099102. Epub 2005 Sep 15. Proc Natl Acad Sci U S A. 2005. PMID: 16166266 Free PMC article.
Targeting protein kinases in central nervous system disorders.
Chico LK, Van Eldik LJ, Watterson DM. Chico LK, et al. Nat Rev Drug Discov. 2009 Nov;8(11):892-909. doi: 10.1038/nrd2999. Nat Rev Drug Discov. 2009. PMID: 19876042 Free PMC article. Review.
Cell cycle inhibition provides neuroprotection and reduces glial proliferation and scar formation after traumatic brain injury.
Di Giovanni S, Movsesyan V, Ahmed F, Cernak I, Schinelli S, Stoica B, Faden AI. Di Giovanni S, et al. Proc Natl Acad Sci U S A. 2005 Jun 7;102(23):8333-8. doi: 10.1073/pnas.0500989102. Epub 2005 May 27. Proc Natl Acad Sci U S A. 2005. PMID: 15923260 Free PMC article.
Roscovitine reduces neuronal loss, glial activation, and neurologic deficits after brain trauma.
Hilton GD, Stoica BA, Byrnes KR, Faden AI. Hilton GD, et al. J Cereb Blood Flow Metab. 2008 Nov;28(11):1845-59. doi: 10.1038/jcbfm.2008.75. Epub 2008 Jul 9. J Cereb Blood Flow Metab. 2008. PMID: 18612315 Free PMC article.
Sustained (S)-roscovitine delivery promotes neuroprotection associated with functional recovery and decrease in brain edema in a randomized blind focal cerebral ischemia study.
Rousselet E, Létondor A, Menn B, Courbebaisse Y, Quillé ML, Timsit S. Rousselet E, et al. J Cereb Blood Flow Metab. 2018 Jun;38(6):1070-1084. doi: 10.1177/0271678X17712163. Epub 2017 Jun 1. J Cereb Blood Flow Metab. 2018. PMID: 28569655 Free PMC article.

Inhibition of cyclin-dependent kinases improves CA1 neuronal survival and behavioral performance after global ischemia in the rat - PubMed (original) (raw)